Table 2 Outcome parameters.
Number (%) or Median (IQR)† | ||||
|---|---|---|---|---|
n | Fecal diversion group | Supported natural defecation group | p value†† | |
Admission to surgery time [days] | 39/201 | 70 (28; 130) | 60 (27; 131) | 0.64 |
Primary microbial infection | 71/392 | 65 (91.5) | 369 (94.1) | 0.41 |
Microbial superinfection | 69/382 | 12 (17.4) | 83 (21.7) | 0.42 |
Time to complete wound healing [days] | 66/379 | 77 (50; 110)* | 59 (44; 86) | 0.02 |
Length of hospital stay [days] | 71/390 | 78 (50; 118)** | 59 (43; 86) | 0.003 |
Length of ICU stay [days] | 71/392 | 2.5 (2; 34.5) | 4.5 (3.25; 22) | 0.65 |
Adverse events during ulcer treatment | 71/392 | 39 (54.9) | 206 (52.6) | 0.71 |
Stage 1 | 1 (2.6) | 14 (6.8) | ||
Stage 2 | 26 (66.7) | 150 (72.8) | ||
Stage 3 | 3 (7.7) | 13 (6.3) | ||
Stage 4 | 6 (15.4) | 21 (10.2) | ||
Stage 5 | 3 (7.7) | 8 (3.9) | ||
Adverse events during stoma surgery | 44 | 11 (25) | n/a | |
Adverse events in total | 71/392 | 48 (67.6) | 221 (56.4) | 0.08 |
Clostridioides difficile infection | 71/392 | 2 (2.8) | 8 (2.0) | 0.68 |
Recurrence [within 3 month] | 71/392 | 2 (2.8) | 11 (2.8) | 1.00 |
New ulcer in the same region [within 3 months] | 71/392 | 7 (9.9) | 23 (5.9) | 0.21 |
Recurrence in total | 71/392 | 9 (12.7) | 34 (8.7) | 0.40 |
